IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Clinical Drug Investigation

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.78

h-Index

2022-2023

 64

Rank

2022-2023

 7379

SJR

2022-2023

 0.680

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Clinical Drug Investigation
Abbreviation Clin. Drug Investig.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)
h-index 64
Overall Rank/Ranking 7379
SCImago Journal Rank (SJR) 0.680
Impact Score 2.78
Publisher Adis International Ltd
Country United Kingdom
ISSN 11791918, 11732563
Best Quartile Q2
Coverage History 1995-2022




Aim and Scope


Clinical Drug Investigation affords rapid access to quality clinical, pharmacoeconomic and outcomes original research.

With rapid, peer-reviewed original findings of the world"s leading drug research teams Clinical Drug Investigation covers:
* Clinical trials
* Outcomes research
* Clinical pharmacoeconomic studies
* Pharmacoepidemiology studies
* Clinical pharmacodynamic and pharmacokinetic studies
* Application of drug-delivery technology in healthcare


About Clinical Drug Investigation


Clinical Drug Investigation is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2). It is published by Adis International Ltd. The overall rank of Clinical Drug Investigation is 7379. According to SCImago Journal Rank (SJR), this journal is ranked 0.680. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 64. The best quartile for this journal is Q2.

The ISSN of Clinical Drug Investigation journal is 11791918, 11732563. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Drug Investigation is cited by a total of 869 articles during the last 3 years (Preceding 2022).


Clinical Drug Investigation Impact IF 2022-2023


The Impact IF 2022 of Clinical Drug Investigation is 2.78, which is computed in 2023 as per its definition. Clinical Drug Investigation IF is decreased by a factor of 0.13 and approximate percentage change is -4.47% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Clinical Drug Investigation Impact IF 2023 Prediction


Impact IF 2022 of Clinical Drug Investigation is 2.78. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Clinical Drug Investigation. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.78
2021 2.91
2020 2.30
2019 2.13
2018 2.27
2017 2.08
2016 2.07
2015 1.97
2014 1.99

Clinical Drug Investigation h-index


  Table Setting

Clinical Drug Investigation has an h-index of 64. It means 64 articles of this journal have more than 64 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Clinical Drug Investigation ISSN


The ISSN of Clinical Drug Investigation is 11791918, 11732563. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Clinical Drug Investigation Rank and SCImago Journal Rank (SJR)


The overall rank of Clinical Drug Investigation is 7379. According to SCImago Journal Rank (SJR), this journal is ranked 0.680. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Clinical Drug Investigation by Year


Year SJR
2023/2024 Coming Soon
2022 0.680
2021 0.718
2020 0.739
2019 0.725
2018 0.731
2017 0.719
2016 0.592
2015 0.664
2014 0.621

Ranking of Clinical Drug Investigation by Year


Year Ranking
2023/2024 Coming Soon
2022 7379
2021 6626
2020 6663
2019 6700
2018 6546
2017 6567
2016 7953
2015 7143
2014 7468

Clinical Drug Investigation Publisher


Table Setting

Clinical Drug Investigation is published by Adis International Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1995-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Clinical Drug Investigation is Clin. Drug Investig.. This abbreviation ('Clin. Drug Investig.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Clinical Drug Investigation


If your research field is/are related to Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Clinical Drug Investigation?

Clinical Drug Investigation latest impact IF is 2.78. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 2.91 (2021) and 1.97 (2015), respectively, in the last 9 years. Moreover, its average IS is 2.28 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Clinical Drug Investigation?

The Clinical Drug Investigation has an SJR (SCImago Journal Rank) of 0.680, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.739 in 2020 and the lowest being 0.592 in 2016. Furthermore, the average SJR of the Clinical Drug Investigation over the previous 9-year period stands at 2.28.


What's the latest h-index of the Clinical Drug Investigation?

The latest h-index of the Clinical Drug Investigation is 64.


Who's the publisher of the Clinical Drug Investigation?

The Clinical Drug Investigation is published by the Adis International Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Clinical Drug Investigation?

The Clinical Drug Investigation is currently ranked 7379 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 6546 in 2018 and its lowest position of 7953 in 2016.


What's the abbreviation or short name for the Clinical Drug Investigation?

The standard ISO4 abbreviation for the Clinical Drug Investigation is Clin. Drug Investig..


Is the "Clinical Drug Investigation" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Clinical Drug Investigation is classified as a journal that the Adis International Ltd publishes.


What's the scope or major areas of the Clinical Drug Investigation?

The Clinical Drug Investigation encompasses the following areas:

  • Medicine (miscellaneous)
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Clinical Drug Investigation?

The Clinical Drug Investigation is assigned the following International Standard Serial Numbers (ISSN): 11791918, 11732563.


What's the best quartile of the Clinical Drug Investigation?

The best quartile for the Clinical Drug Investigation is Q2 (2022).


What's the coverage history of the Clinical Drug Investigation?

The Clinical Drug Investigation coverage history can be summarized as follows: 1995-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Current Sociology journal 6591 SAGE Publications Ltd 76 2.29
Socialism and Democracy journal 26162 Taylor and Francis Ltd. 17 0.09
Sex Education journal 5168 Routledge 41 2.82
Syntax journal 3422 Wiley-Blackwell Publishing Ltd 29 0.93
Population Review journal 17841 Sociological Demography Press 13 0.73
Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute journal 25369 Hoikkaido Forest Products Research Institute 4 0.00
Geo-Info journal 30490 Nederlandse Vereniging voor Kartografie 2 0.00
Economics of Innovation and New Technology journal 6153 Routledge 62 3.55
Endangered Species Research journal 4658 Inter-Research 66 3.20
Journal of Agricultural, Food, and Environmental Sciences (discontinued) journal 22910 Global Commerce and Communication, Inc. 5 0.00

Check complete list




Year wise Impact Score (IS) of Clinical Drug Investigation

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.78
2021 2.91
2020 2.30
2019 2.13
2018 2.27
2017 2.08
2016 2.07
2015 1.97
2014 1.99



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All